KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest Expenses (2016)

AbbVie (ABBV) has disclosed Interest Expenses for 5 consecutive years, with $245.0 million as the latest value for Q2 2016.

  • On a quarterly basis, Interest Expenses rose 42.44% to $245.0 million in Q2 2016 year-over-year; TTM through Mar 2017 was $245.0 million, a 75.98% decrease, with the full-year FY2015 number at $719.0 million, up 67.6% from a year prior.
  • Interest Expenses was $245.0 million for Q2 2016 at AbbVie, up from $215.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $425.0 million in Q3 2015 to a low of $70.0 million in Q1 2014.
  • A 5-year average of $148.0 million and a median of $132.0 million in 2015 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: fell 21.28% in 2013, then surged 189.12% in 2015.
  • AbbVie's Interest Expenses stood at $94.0 million in 2012, then fell by 21.28% to $74.0 million in 2013, then skyrocketed by 87.84% to $139.0 million in 2014, then surged by 49.64% to $208.0 million in 2015, then rose by 17.79% to $245.0 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Interest Expenses are $245.0 million (Q2 2016), $215.0 million (Q1 2016), and $208.0 million (Q4 2015).